{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:09:07Z","timestamp":1782961747857,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800401"],"award-info":[{"award-number":["81800401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["2019-YL13"],"award-info":[{"award-number":["2019-YL13"]}],"id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejphar.2022.175034","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:25:13Z","timestamp":1652725513000},"page":"175034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cyclosporin A up-regulated thromboxane A2 receptor through activation of MAPK and NF-\u03baB pathways in rat mesenteric artery"],"prefix":"10.1016","volume":"926","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-0113","authenticated-orcid":false,"given":"Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cang-Bao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175034_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0000000000002445","article-title":"Blood pressure in de novo heart transplant recipients treated with everolimus compared with a cyclosporine-based regimen: results from the randomized SCHEDULE trial","volume":"103","author":"Andreassen","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2022.175034_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2022.175034_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1054-3589(08)60276-8","article-title":"In vivo pharmacological effects of ciclosporin and some analogues","volume":"35","author":"Borel","year":"1996","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib4","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.transproceed.2004.01.042","article-title":"Cyclosporine as a milestone in immunosuppression","volume":"36","author":"Calne","year":"2004","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejphar.2022.175034_bib5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.12472","article-title":"Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation","volume":"12","author":"Capra","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2022.175034_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108755","article-title":"Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia\/reperfusion injury via regulating MAPK\/NF-kappaB signaling","volume":"108","author":"Chen","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2022.175034_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12364","article-title":"The pro-inflammatory cytokine TNF-alpha inhibits lymphatic pumping via activation of the NF-kappaB-iNOS signaling pathway","volume":"24","author":"Chen","year":"2017","journal-title":"Microcirculation"},{"key":"10.1016\/j.ejphar.2022.175034_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.vph.2016.08.011","article-title":"Homocysteine regulates endothelin type B receptors in vascular smooth muscle cells","volume":"87","author":"Chen","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2015-03-631937","article-title":"A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)","volume":"126","author":"Choi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2022.175034_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/ATVBAHA.121.317380","article-title":"A thromboxane A2 receptor-driven COX-2-dependent feedback loop that affects endothelial homeostasis and angiogenesis","volume":"42","author":"Eckenstaler","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2022.175034_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvu015","article-title":"Interactions between thromboxane A(2), thromboxane\/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization","volume":"102","author":"Ellinsworth","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2022.175034_bib12","first-page":"175","article-title":"Cyclosporin A in renal transplantation: a prospective randomized trial","volume":"92","author":"Ferguson","year":"1982","journal-title":"Surgery"},{"key":"10.1016\/j.ejphar.2022.175034_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.HYP.0000112225.27560.24","article-title":"Role for thromboxane receptors in angiotensin-II-induced hypertension","volume":"43","author":"Francois","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2022.175034_bib14","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1097\/00004872-198900076-00132","article-title":"Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strain","volume":"7","author":"Geoffroy","year":"1989","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.ejphar.2022.175034_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-022-01927-9","article-title":"Notch4 mediates vascular remodeling via ERK\/JNK\/P38 MAPK signaling pathways in hypoxic pulmonary hypertension","volume":"23","author":"Guo","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2022.175034_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/oxfordjournals.ndt.a027761","article-title":"Cyclosporin A-associated hypertension--pathomechanisms and clinical consequences","volume":"12","author":"Haas","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2022.175034_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13033","article-title":"Cyclosporine A induces endothelin-converting enzyme-1: studies in vivo and in vitro","volume":"223","author":"Heyman","year":"2018","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2022.175034_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjp.0704416","article-title":"Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan","volume":"134","author":"Katugampola","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cbi.2007.07.008","article-title":"Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells","volume":"171","author":"Kim","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2022.175034_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2010.06.001","article-title":"Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis","volume":"128","author":"Kockx","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175034_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaad.2019.04.053","article-title":"Cyclosporine for moderate-to-severe alopecia areata: a double-blind, randomized, placebo-controlled clinical trial of efficacy and safety","volume":"81","author":"Lai","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejphar.2022.175034_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ejphar.2010.10.038","article-title":"Enhanced airway smooth muscle cell thromboxane receptor signaling via activation of JNK MAPK and extracellular calcium influx","volume":"650","author":"Lei","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib23","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1074\/jbc.M115.683052","article-title":"Thromboxane A2 receptor inhibition suppresses multiple myeloma cell proliferation by inducing p38\/c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK)-mediated G2\/M progression delay and cell apoptosis","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.175034_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00277-020-03926-6","article-title":"Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective","volume":"99","author":"Liu","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejphar.2022.175034_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clim.2008.12.007","article-title":"Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome","volume":"131","author":"Liu","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2022.175034_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2022.175034_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vph.2018.06.012","article-title":"Treatment of cyclosporine induced hypertension: results from a long-term observational study using different antihypertensive medications","volume":"115","author":"Marienhagen","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vph.2019.02.002","article-title":"Drug-induced hypertension: know the problem to know how to deal with it","volume":"115","author":"Masi","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175034_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fphar.2019.01244","article-title":"Measurement of thromboxane biosynthesis in health and disease","volume":"10","author":"Patrono","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib31","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3324\/haematol.2018.206540","article-title":"Immunosuppressive therapy for pediatric aplastic anemia: a north American pediatric aplastic anemia consortium study","volume":"104","author":"Rogers","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2022.175034_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2014.07.048","article-title":"Thromboxane A2 stimulates neurite outgrowth in cerebral cortical neurons via mitogen activated protein kinase signaling","volume":"1594","author":"Sumimoto","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2022.175034_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biotechadv.2011.03.004","article-title":"Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications","volume":"29","author":"Survase","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejphar.2022.175034_bib34","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0025-6196(12)65772-3","article-title":"Cyclosporine-induced hypertension after transplantation","volume":"69","author":"Textor","year":"1994","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2022.175034_bib35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","article-title":"Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts","volume":"92","author":"Unal","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2022.175034_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2022.106631","article-title":"Thromboxane-dependent coronary vasoconstriction in obese mice: role of peroxynitrite","volume":"160","author":"Villa-Martinez","year":"2022","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejphar.2022.175034_bib37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.117.309139","article-title":"Increased hepatic expression of endothelial lipase inhibits cholesterol diet-induced hypercholesterolemia and atherosclerosis in transgenic rabbits","volume":"37","author":"Wang","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2022.175034_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.fct.2018.06.054","article-title":"Mechanism of cyclosporine A nephrotoxicity: oxidative stress, autophagy, and signalings","volume":"118","author":"Wu","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175034_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/toxsci\/kfv229","article-title":"The role of MAPK pathways in airborne fine particulate matter-induced upregulation of endothelin receptors in rat basilar arteries","volume":"149","author":"Xiao","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2022.175034_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1742-7843.2010.00585.x","article-title":"Up-regulation of G-protein-coupled receptors for endothelin and thromboxane by lipid-soluble smoke particles in renal artery of rat","volume":"107","author":"Xie","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175034_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2010.04.013","article-title":"Cardiovascular risk factors regulate the expression of vascular endothelin receptors","volume":"127","author":"Xu","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175034_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vph.2013.11.004","article-title":"Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression","volume":"60","author":"Xu","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115420","article-title":"Sorafenib not only impairs endothelium-dependent relaxation but also promotes vasoconstriction through the upregulation of vasoconstrictive endothelin type B receptors","volume":"414","author":"Yu","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175034_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000045184","article-title":"Hypertension in the transplanted patient","volume":"80","author":"Zeier","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2022.175034_bib45","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2007.06.031","article-title":"Up-regulation of thromboxane A2 receptor expression by lipid soluble smoking particles through post-transcriptional mechanisms","volume":"196","author":"Zhang","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2022.175034_bib46","first-page":"6507048","article-title":"Downregulation of thromboxane A2 receptor occurs mainly via nuclear factor-KappaB signaling pathway in rat renal artery","volume":"2017","author":"Zhang","year":"2017","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.175034_bib47","doi-asserted-by":"crossref","first-page":"153083","DOI":"10.1016\/j.prp.2020.153083","article-title":"The roles of endothelin and its receptors in cigarette smoke-associated pulmonary hypertension with chronic lung disease","volume":"216","author":"Zhang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejphar.2022.175034_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2015.03.004","article-title":"Cyclosporin A upregulates ETB receptor in vascular smooth muscle via activation of mitogen-activating protein kinases and NF-kappaB pathways","volume":"235","author":"Zheng","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2022.175034_bib49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/bcpt.12105","article-title":"Vasomotor dysfunction in the mesenteric artery after organ culture with cyclosporin A","volume":"113","author":"Zheng","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:02:09Z","timestamp":1757977329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":49,"alternative-id":["S0014299922002953"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporin A up-regulated thromboxane A2 receptor through activation of MAPK and NF-\u03baB pathways in rat mesenteric artery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175034"}}